Roche, Medicines Patent Pool sign deal to expand access to influenza drug

Roche and the Medicines Patent Pool signed a licensing agreement to expand access to Xofluza in low- and middle-income countries. The deal is intended to boost supply during seasonal outbreaks and potential pandemics, supporting broader availability of the flu drug. The news is positive for access and distribution, but likely limited in direct near-term market impact.

Analysis

Roche and the Medicines Patent Pool signed a licensing agreement to expand access to Xofluza in low- and middle-income countries. The deal is intended to boost supply during seasonal outbreaks and potential pandemics, supporting broader availability of the flu drug. The news is positive for access and distribution, but likely limited in direct near-term market impact.